Why should be herpes simplex infection be treated? Review article
Article Sidebar
Published:
Dec 31, 2024
Keywords:
herpes simpex, herpes labialis, virus, acyclovir
Main Article Content
Abstract
Herpes labialis is a common, recurrent and troublesome disease for the patient. Symptoms may disappear spontaneously, but the use of causal treatment (acyclovir) shortens the duration of the disease, reduces the burden of symptoms, prevents complications and prevents relapses. It is possible to use acyclovir orally with additional local treatment in the form of a cream or patches. Acyclovir should be used in treatment as early as possible (when prodromal symptoms appear), it can also be used prophylactically.
Article Details
How to Cite
Nitsch-Osuch, A. (2024). Why should be herpes simplex infection be treated?. Medycyna Faktow (J EBM), 17(4(65), 512-515. https://doi.org/10.24292/01.MF.0424.12
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Opryszczka.
2. Saleh D, Yarrarapu SNS, Sharma S. Herpes Simplex Type 1. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL) 2024.
3. Costello M, Sabatini L, Yungbluth P et al. Herpes Simplex Virus infections and current methods for laboratory detection. Clin Microbiol Newsl. 2006; 28: 185-92.
4. Logan HL, Lutgendorf S, Hartwig A et al. Immune, stress, and mood markers related to recurrent oral herpes outbreaks. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86(1): 48-54.
5. Vestin E, Boström G, Olsson J et al. Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study. J Alzheimers Dis. 2024; 97(4): 1841-50.
6. Lesiak J, Narbutt A. Kompleksowe leczenie opryszczki wargowej. Forum Dermatologicum. 2017; 3(4): 147-51.
7. Spruance SL, Hamill ML, Hoge WS et al. Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA. 1988; 260(11): 1597-9.
8. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008; 168(11): 1137-44.
9. Kuchar E. Opryszczka (zakażenie wirusem opryszczki zwykłej) – przyczyny, objawy, leczenie.
10. Korzeniewska-Rybicka IA. Acyklowir – przełom sprzed 40 lat. Medical Tribune. 2015; (1): 78-80.
11. Charakterystyka produktu leczniczego Heviran Comfort MAX.
12. Kaszuba A, Adamski Z, Majewski S. Acyklowir – wskazówki kliniczne. Dermatologia Praktyczna. 2012; 1(18): 46-5.
13. Raborn GW, McGaw WT, Grace M et al. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo controlled study. J Am Dent Assoc. 1987; 115(1): 38-42.
2. Saleh D, Yarrarapu SNS, Sharma S. Herpes Simplex Type 1. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL) 2024.
3. Costello M, Sabatini L, Yungbluth P et al. Herpes Simplex Virus infections and current methods for laboratory detection. Clin Microbiol Newsl. 2006; 28: 185-92.
4. Logan HL, Lutgendorf S, Hartwig A et al. Immune, stress, and mood markers related to recurrent oral herpes outbreaks. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86(1): 48-54.
5. Vestin E, Boström G, Olsson J et al. Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study. J Alzheimers Dis. 2024; 97(4): 1841-50.
6. Lesiak J, Narbutt A. Kompleksowe leczenie opryszczki wargowej. Forum Dermatologicum. 2017; 3(4): 147-51.
7. Spruance SL, Hamill ML, Hoge WS et al. Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA. 1988; 260(11): 1597-9.
8. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008; 168(11): 1137-44.
9. Kuchar E. Opryszczka (zakażenie wirusem opryszczki zwykłej) – przyczyny, objawy, leczenie.
10. Korzeniewska-Rybicka IA. Acyklowir – przełom sprzed 40 lat. Medical Tribune. 2015; (1): 78-80.
11. Charakterystyka produktu leczniczego Heviran Comfort MAX.
12. Kaszuba A, Adamski Z, Majewski S. Acyklowir – wskazówki kliniczne. Dermatologia Praktyczna. 2012; 1(18): 46-5.
13. Raborn GW, McGaw WT, Grace M et al. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo controlled study. J Am Dent Assoc. 1987; 115(1): 38-42.